Aglycosylated antibodies and the methods of making and using them: WO2008030564.
about
Revisiting the role of glycosylation in the structure of human IgG Fc.Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG.Galactosylation variations in marketed therapeutic antibodies.Mutational deglycosylation of the Fc portion of immunoglobulin G causes O-sulfation of tyrosine adjacently preceding the originally glycosylated site.
P2860
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
@en
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
@nl
type
label
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
@en
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
@nl
prefLabel
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
@en
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
@nl
P2860
P1476
Aglycosylated antibodies and the methods of making and using them: WO2008030564.
@en
P2093
Roy Jefferis
P2860
P304
P356
10.1517/13543770802592408
P407
P577
2009-01-01T00:00:00Z